The published research on longevity supplement ingredients has matured significantly since 2020. The following summarises the current state of the evidence base — not as health claims, but as factual descriptions of what has been studied and published. For full references, see our research references page →
NMN research
A systematic review (Yi et al. 2023) covering 10 randomised controlled trials with 437 participants documented that NMN supplementation consistently elevated blood NAD+ levels across doses from 250 to 900mg per day, with a strong safety profile and no significant adverse events. Multiple individual peer-reviewed human studies have explored NMN across a range of research areas. See the full NMN dosage guide →
Resveratrol research
Resveratrol is one of the most studied polyphenols in the published scientific literature. Its relationship to sirtuin enzymes — particularly SIRT1 — has been documented extensively in both in vitro and in vivo research. Human studies have explored resveratrol across metabolic, cardiovascular and longevity biology contexts. See our NMN and Resveratrol guide →
AHCC research
AHCC has one of the most extensive published research bases of any mushroom-derived supplement ingredient, with human studies published since the early 1990s across multiple research contexts.
The important caveat: The above describes what has been studied and published about these compounds as substances — not what supplement products containing them will do. Product quality, purity and dose are critical factors. Independent batch testing at stated doses is the only way to verify you are consuming what the label states.